Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
65 participants
INTERVENTIONAL
2007-04-30
2008-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Study of Different Sedative Medications in Monitored Anesthesia Care During Eye Surgery With Local Anesthesia
NCT04018703
A Phase 1 Study To Characterize The Safety, Tolerability, PK And PK Of Repeat Doses Of PF-06648671 In Healthy Adults And Healthy Elderly Subjects
NCT02440100
Minimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep
NCT02856594
Oral Versus Intravenous Sedation for Ocular Procedures
NCT03246724
Sedation and Pain (The Effect of IV Sedation on Pain Perception)
NCT00853333
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
propofol
active drug
propofol
sedative
dexmedetomidine
sedative
dexmedetomidine
Sedative
midazolam
Sedative
Midazolam
sedative
placebo
placebo control
saline placebo
saline placebo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
propofol
sedative
dexmedetomidine
Sedative
Midazolam
sedative
saline placebo
saline placebo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Respiratory disease (severe asthma, emphysema)
* Cardiac disease (coronary artery disease, congestive heart failure)
* Symptomatic reflux disease
* Advanced rheumatic disease involving cervical spine
* Propofol or egg allergy
* Neurological disease (stroke, intracranial processes)
* Severe anemia
19 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Center for Research Resources (NCRR)
NIH
University of Alabama at Birmingham
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michael Froelich
M.D
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
General Clinical Research Center
Birmingham, Alabama, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
F050721005
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.